Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
3,530.00    -205.00 (-5.49%)
Bid:
3,525.00
Ask:
3,545.00
Spread: 20.00 (0.567%)
Market Cap: $927.20b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

Decision on Share Repurchase

18 Feb 2025 10:21

RNS Number : 5359X
Samsung Electronics Co. Ld
18 February 2025
Β 

Decision on Share Repurchase

Β 

Β 

1.Β Number of shares to be repurchased

Common

48,149,247

Other

6,636,988

2.Β Value of shares to be repurchased (Korean won)

Common

2,696,357,832,000

Other

303,642,201,000

3.Β Expected repurchase period

Start date

February 19, 2025

End date

May 16, 2025

4.Β Purpose of repurchase

To increase shareholder value and conduct employee stock-based compensation, etc.

5.Β Method ofΒ repurchase

Open market

6.Β Consignment investment brokers

Samsung Securities Co., Ltd.

Korea Investment & Securities Co, Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

IBK Securities Co.,Ltd

7. Holding status of treasury shares before repurchase

Repurchase within the allowable distribution profit (shares)

Common

50,144,628

Ratio (%)

0.8

Other

6,912,036

Ratio (%)

0.8

Other repurchase (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

8.Β Date ofΒ board resolution (confirmation date)

February 18, 2025

-Β Attendance ofΒ Independent Directors at the Board of Directors meeting

Present

6

Absent

0

- Attendance of auditors who are not

Β Independent Directors

0

9.Β Daily order quantity limit

Common

5,246,563

Other

663,698

Β 

10.Β Other Information to Consider:

- Shares denoted as "other" are preferred shares.

- In Item 2 above, the value of shares to be repurchased is based on the closing price on the day before the board resolution (February 17, 2025). The actual amount may change depending on future stock price movements.

Β β€» KRW 56,000 per common share and KRW 45,750 per preferred share

-In Item 4, the expected holding period and purpose of repurchase, in accordance with the Board resolution on February 18, 2025, shares worth KRW 500 billion are to be acquired for the purpose of the stock-based compensation including employee incentives, etc. The remaining KRW 2.5 trillion is to be acquired for the purpose of stabilizing the stock price and enhancing shareholder value.

Further details, including timing of cancellation and the actual number of shares to be cancelled, will be disclosed following the resolution of the Board of Directors in the future.

* To enhance motivation for business performance and enhance shareholder value, the Company has decided to implement a stock-based compensation program (RSA) for executive compensation. Under this program, stock-based compensation will constitute 50% or more of the 2024 Overall Performance Incentive (OPI). The Company plans to allocate a portion of the repurchased shares, amounting to approximately KRW 500 billion, to the RSA program.

* Under the RSA framework, the number of treasury shares for each executive was determined in January 2025 based on individual selections. The final allocation will be confirmed one year later, considering the stock price at that time. Once granted, executives will be restricted from selling the shares for a period of one to two years, in accordance with the program's terms.

- In Item 8 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 9 above is the smaller of: [β‘’] and [the larger of β‘  and β‘‘].

Β β‘  10% of the number of shares to be repurchased: 4,814,924 common; 663,698 preferred

Β β‘‘ 25% of average daily transaction volume for one month ending the day before the date of the board resolution: 5,246,563 common; 319,492 preferred

Β β‘’ 1% of total number of issued shares: 59,697,825 common; 8,228,867 preferred

Β 

- No shares were repurchased prior to the decision to repurchase shares.

Β 

- Limit on the amount of repurchased shares (Korean won)

1.Β Limits toΒ Dividendable profit under Commercial Act as of end-2024

226,239,016,662,399

2.Β Amount of repurchased shares since end-2024

1,237,265,394,240

3.Β Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2024

-

4.Β The interim dividend amount and related profit reserves decided by the board of directors since end-2024

-

Limit on the amount of repurchased shares

(1-2-3-4)

225,001,751,268,159

Β 

- Holding status of treasury shares before purchase (number of shares)

* on-market direct purchase

Stock type

Initial quantity

Changes

End quantity

purchase

disposal

cancellation

common

-

50,144,628

-

-

50,144,628

other

-

6,912,036

-

-

6,912,036

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCMZGMZGRLGKZM
12
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.